0623 Broadcast DATE: July 7, 2008 SUBJECT: Form Revision Notice - F1/FS Revisions on Multiple Studies Form Revision Multiple RTOG Studies F1/FS revisionr The following forms have been revised. Download the new version from the RTOG web site at http://www.rtog.org/members/forms/list.html The edition code for case report forms is found in the lower right corner of the form. Form Type New Version Code/Date 522F1    522F1c     7-3-08 822F1    822F1a     6-26-08 630F1a    630F1b     6-26-08 623F1    623F1a     6-26-08 618F1    618F1a     6-26-08 617F1a    617F1b     6-26-08 615F1b    615F1c     6-26-08 529F1    529F1a     6-26-08 438F1c    438F1d     6-26-08 435FSb    435FSc     6-26-08 435F1b    435F1c     6-26-08 421F1    421F1a     7-2-08 418F1    418F1a     6-26-08 417F1    417F1a     6-26-08 411F1a    411F1b     6-26-08 330F1a    330F1b     6-26-08 247F1b    247F1c     6-26-08 234F1b    234F1c     7-1-08   Changes Made: These all involved changes to the Progression and/or New Primary Tables. Discard obsolete versions and commence use of the revised editions immediately. Obsolete versions received on or after July 15, 2008 will be returned to the site for transcription. Please notify your joint center institutions and affiliates who are not on e-mail. Wendy Bergantz, RN RTOG Data Management Web registration is available 24/7. Information and instructions are at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: April 22, 2008 SUBJECT: Web-Based Electronic Data Submission WEB-BASED ELECTRONIC DATA SUBMISSION Web-Based Electronic Data Submission is now available for the following RTOG forms: 0614 T1 Radiotherapy Form 0623 TI Radiotherapy Form Per previous Broadcasts, web-based data submission became MANDATORY as of May 14, 2007 for all forms available for web-entry for all cases enrolled through RTOG. A complete listing of forms available for web data submission is available at http://www.rtog.org/members/webreg.htm For technical support with web data submission, please email websupport@phila.acr.org. Web registration is available 24/7. Information and instructions are at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: February 5, 2008 SUBJECT: RTOG 0623, Updated Updated RTOG 0623, “A Phase II Trial Of Combined Modality Therapy With Growth Factor Support For Patients With Limited Stage Small Cell Lung Cancer“: Update: The CALGB Co-Chairs were removed from the title page, and a word was corrected in Appendix I, the sample consent. Sites can access the complete summary of changes at http://www.rtog.org/members/protocols/0623/summary_changes.html Sites can download a copy of the protocol for IRB review by accessing the RTOG web site at http://www.rtog.org/members/protocols/0623/0623.pdf NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by RTOG to NCI; for clarity, the broadcast date is provided in parentheses. The "Update Date" indicates that editorial/administrative changes were made to the protocol after NCI approved the amendment. NCI requires that these changes be documented on the protocol title page as an update, not as an amendment. IRB review of an update is not required; however, these changes must be reported to site IRBs. Please notify your affiliates that are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. If you would like to be added or removed from the RTOG broadcast list or wish to update your e-mail address, contact Michelle Buado at mbuado@phila.acr.org Web registration is available 24/7. Information and instructions available at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: January, 15, 2008 SUBJECT: RTOG 0623, Updated Updated RTOG 0623, "A Phase II Trial Of Combined Modality Therapy With Growth Factor Support For Patients With Limited Stage Small Cell Lung Cancer": Update: All references to an IND for filgrastim were deleted as this is an IND exempt study. Sites can access the complete summary of changes at http://www.rtog.org/members/protocols/0623/summary_changes.html Sites can download a copy of the protocol for IRB review by accessing the RTOG web site at http://www.rtog.org/members/protocols/0623/0623.pdf NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by RTOG to NCI; for clarity, the broadcast date is provided in parentheses. The "Update Date" indicates that editorial/administrative changes were made to the protocol after NCI approved the amendment. NCI requires that these changes be documented on the protocol title page as an update, not as an amendment. IRB review of an update is not required; however, these changes must be reported to site IRBs. Please notify your affiliates that are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. If you would like to be added or removed from the RTOG broadcast list or wish to update your e-mail address, contact Michelle Buado at mbuado@phila.acr.org Web registration is available 24/7. Information and instructions available at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: January, 8, 2008 SUBJECT: RTOG 0623, Activated Activated RTOG 0623, "A Phase II Trial Of Combined Modality Therapy With Growth Factor Support For Patients With Limited Stage Small Cell Lung Cancer" You may download a copy of the protocol for IRB review by accessing the RTOG web site at http://www.rtog.org/members/protocols/0623/0623.pdf Forms for this study are available on the RTOG web site at http://www.rtog.org/members/forms/0623/main.html Note: A Study Agent Shipment Form for this study is available on the RTOG web site next to the protocol. Regulatory Notes: NCI policy requires that the "Version Date" of the protocol reflect the date that the protocol was submitted by RTOG to NCI; therefore, the version date and the activation date on the protocol title page are not the same. The "Update Date" (the same as the activation date) indicates that minor administrative changes were made to the protocol after NCI approval; these changes are detailed in a summary of changes that can be accessed at http://www.rtog.org/members/protocols/0623/summary_changes.html Please notify your affiliates who are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. If you would like to be added or removed from the RTOG broadcast list or wish to update your e-mail address, contact Michelle Buado at mbuado@phila.acr.org Web registration is available 24/7. Information and instructions available at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html